Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11426393 Prolyl hydroxylase inhibitors and methods of use

Patent 11426393 was granted and assigned to Akebia Therapeutics on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Akebia Therapeutics

0

Current Assignee

Akebia Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Angelique Sun Boyer0

Shengde Wu0

Richard Masaru Kawamoto0

Namal C. Warshakoon0

Kenneth D. Greis0

Artem G. Evdokimov0

Date of Patent

August 30, 2022

0

Patent Application Number

169080920

Date Filed

June 22, 2020

0

Patent Citations

US Patent 10246416 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides

US Patent 10150734 Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof

US Patent 10149842 Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

US Patent 11267785 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides

US Patent 11065237 Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

US Patent 10738010 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides

US Patent 10729681 Prolyl hydroxylase inhibitors and methods of use

US Patent 10596158 Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

0

Patent Citations Received

US Patent 11883386 Prolyl hydroxylase inhibitors and methods of use

0

Patent Primary Examiner

Daniel R Carcanague

0

CPC Code

0

0

The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11426393 Prolyl hydroxylase inhibitors and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.